3 results match your criteria: "University of MA Chan Medical School-Baystate[Affiliation]"
Perceptions of extended-release buprenorphine among people who received medication for opioid use disorder in jail: a qualitative study.
Addict Sci Clin Pract
September 2024
Department of Health Promotion and Policy, School of Public Health and Health Sciences, University of Massachusetts Amherst, 312 Arnold House, 715 North Pleasant Street, Amherst, MA, 01003, USA.
Background: Incarceration provides an opportunity for health interventions, including opioid use disorder (OUD) treatment and prevention of opioid-related overdoses post-release. All FDA-approved forms of medication for OUD (MOUD) treatment were mandated in several Massachusetts jails in 2019, with some jails offering extended-release buprenorphine (XR-Bup). Little is known about patient perspectives on and experiences with XR-Bup in carceral settings.
View Article and Find Full Text PDFDiffusion of medications for opioid use disorder treatment in jail settings: a convergent mixed methods study of jail staff perspectives.
Addict Sci Clin Pract
February 2024
Department of Medicine, University of MA Chan Medical School-Baystate, 759 Chestnut St, Springfield, MA, 01199, USA.
Article Synopsis
- The study investigates how the organizational climate in jails affects staff perceptions of medications for opioid use disorder (MOUD) and highlights the variability of MOUD implementation across different facilities and states.! -
- Using surveys and interviews, researchers found that a positive organizational climate and staff training significantly enhance perceptions of the acceptability and knowledge of MOUD, particularly methadone and buprenorphine.! -
- The findings emphasize that improving organizational climate and providing educational resources are crucial for the effective implementation of MOUD programs in jails, leading to better outcomes for incarcerated populations.!
Association of spatial proximity to fixed-site syringe services programs with HCV serostatus and injection equipment sharing practices among people who inject drugs in rural New England, United States.
Harm Reduct J
January 2024
Office of Research, University of MA Chan Medical School - Baystate, Springfield, MA, USA.
Background: Hepatitis C virus (HCV) disproportionately affects rural communities, where health services are geographically dispersed. It remains unknown whether proximity to a syringe services program (SSP) is associated with HCV infection among rural people who inject drugs (PWID).
Methods: Data are from a cross-sectional sample of adults who reported injecting drugs in the past 30 days recruited from rural counties in New Hampshire, Vermont, and Massachusetts (2018-2019).